Spotlight

Real World Evidence (RWE) has long been heralded as a “game changer” for the life sciences industry. Real World Evidence is the term used to describe research findings that use data that is gathered outside of standard clinical trials. This informative whitepaper highlights the growth, importance, and benefits of Real World Evidence data to the pharma industry. Does it address the questions such as: Why Real-World Evidence (RWE) is an important driver of decision-making in healthcare? How does Real World Evidence analytics accelerate the Improved patient Journey and decision making?

OTHER LIVE WEBINARS

Health Innovation through Capital and Private Equity Markets webinar

February 23, 2022 | 1:00PM GMT

Across the world, there is a new appreciation that health innovation is essential for driving forward better quality and access to healthcare. Yet, there is a huge funding gap especially for low and middle-income countries (LMICs). With the demand for innovation, we are seeing an increase in the use of capital and private equity markets for funding health innovation. Health systems as well as start-ups in HealthTech and hospitals are collaborating with private equity firms to finance health innovation. In this webinar, we ask a panel of financial experts and innovators to address the question of whether capital and private equity markets are actually driving forward better and sustainable health innovation.
Register Now

Role of Robotics in Rehabilitation- How to Research and Measure

January 27, 2022 | 1:00PM GMT

AiBle is a 3-year cross-border EU Interreg project about an upper-limb rehabilitation exoskeleton robot based on AI and cloud computing. The workshop objective is to create a discussion platform on intersections between the fields of rehabilitation, robotics, and human-computer/robot interaction.
Register Now

Spotlight

Real World Evidence (RWE) has long been heralded as a “game changer” for the life sciences industry. Real World Evidence is the term used to describe research findings that use data that is gathered outside of standard clinical trials. This informative whitepaper highlights the growth, importance, and benefits of Real World Evidence data to the pharma industry. Does it address the questions such as: Why Real-World Evidence (RWE) is an important driver of decision-making in healthcare? How does Real World Evidence analytics accelerate the Improved patient Journey and decision making?

resources